Valneva wins new U.S. contract for Japanese encephalitis vaccine, Ixiaro

Close Up of Pen on Contract

peepo

  • French biotech Valneva (NASDAQ:VALN) (OTCPK:INRLF) announced Thursday that the company signed a new one-year contract worth $32.8M with the U.S. Department of Defense to supply its Japanese encephalitis vaccine, branded as Ixiaro.
  • The deal, which takes effect immediately, allows the DoD to

Leave a Reply

Your email address will not be published. Required fields are marked *